ET Pharma

Adopting multi-faceted approach towards ROI key to digital transformation of Pharma: Experts At a panel discussion themed on ‘Embracing Pharma 4.0: Harnessing Technology Along the Entire Drug Journey’ the experts shared that due to #complex_regulations and #investment_deficit the Industry lacks the foundational requirements to undergo a complete transition and undertake #data_drivenanalysis. They also voiced that innovations like #AI will have a larger impact on #R_D rather than the existing manufacturing process. #Pharma4_0 I #Digital_Transformation I #Automation I #AI I #Cloud_Computing I #ROI I #Regulations I #Data_Integration I Dheeraj Sinha I Tushar Zade I Shirish G Belapure I Rakesh Bhardwaj I Vikas Dandekar I Sun Pharmaceuticals I Lupin I Indian Pharmaceutical Alliance I Aurigene Pharmaceutical Services Limited Read more: https://lnkd.in/gGv976bq

Is Indian Pharma Market on the Track to reach $130 Billion by 2030? The #Indianpharmaceutical_industry has experienced transformative growth and #challenges in 2024, making it a pivotal year for innovation, sustainability, and global competitiveness. With advancements in drug discovery, regulatory shifts, and the integration of #digital_technologies, Indian pharma continues to shape global healthcare trends while addressing domestic needs through government initiatives like #AyushmanBharat and the Production-Linked Incentive (#PLI) scheme. ETPharma brings together eminent leaders in the Indian pharmaceutical industry to discuss the major achievements and outlook for year 2025 Live Webinar on: December 4th, 2024, 12:00 pm onwards Speakers: Sudarshan Jain I Dr SV Veeramani I Sheetal Sapale I Vikas Dandekar I Rashmi Mabiyan Kaur #PharmaIndustry I #Growth_Prospects I #Domesticmarket I #Exports I #Estimates I #Generics I #Biosimilars I #Innovative_Drugs Register to join the webinar: https://lnkd.in/ggppfAqi

Indian pharma poised for Robust Growth, Likely to Benefit from Biosecure Act: Experts Speaking at the inaugural panel discussion at the ETPharma Tech Innovate Conclave, top industry experts highlighted that innovations such as #AI, #automation, and digital tools will play a critical role in optimising #manufacturing processes, improving drug efficacy and quality, and simplifying drug administration techniques. Experts also emphasized that, contrary to popular belief, the U.S. #Biosecure_Act is likely to benefit India in the long run and will open significant #opportunities for Indian companies. #Automation | #PharmaFuture | #LeanManufacturing | #PatientCentricity | #PrecisionMedicine I Dr. Sanjeev Panchal | AstraZeneca India | Achin Gupta | Cipla | Amrut Medhekar | shirish belapure | Vikas Dandekar | Prathiba Raju I Akums Drugs& Pharmaceuticals Ltd I Indian Pharmaceutical Alliance Read more: https://lnkd.in/eXWfxtqy

We are pleased to welcome Archana Jatkar, Associate Secretary General of the Indian Pharmaceutical Alliance, as a distinguished speaker at the ET Pharma Future Ready Supply Chain Summit. Ms. Jhatkar brings deep expertise in advancing the pharmaceutical industry’s growth and fostering regulatory excellence. She will provide valuable perspectives on aligning industry practices with evolving global standards and driving innovation across the supply chain ecosystem. Register Now: https://bit.ly/3BkhWRf #ETPharmaSummit #SupplyChainExcellence #PharmaInnovation #FutureReadySupplyChain #PharmaLogistics

We are delighted to announce Prashant Sharma, Chief Technical Officer at Zydus Group, as a speaker at the ET Pharma Future Ready Supply Chain Summit. With extensive expertise in pharmaceutical technologies and innovation, Mr. Sharma will shed light on integrating cutting-edge solutions to enhance efficiency and resilience in pharma supply chains. Join us to gain valuable insights from a leader driving transformation in the healthcare sector. Register Now: https://bit.ly/3BkhWRf #ETPharmaSummit #SupplyChainExcellence #PharmaInnovation #FutureReadySupplyChain #PharmaLogistics

Biocon Biologics gets US nod to launch Stelara biosimilar Biocon Biologics will be able to launch the drug in the US no later than on February 22, 2025, as per the settlement and licensing agreement with Janssen. Stelara is the top selling drug for Janssen with sales of $7 billion in the US in 2023.The biosimilar will be marketed under brand name Yesintek. #pharma | #medicine | #drugdevelopment | #drugapproval | #druglaunch Read more: https://lnkd.in/evTeJupP

Jamia prof receives Rs 94 lakh grant to formulate AI-driven drug to treat breast cancer The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment. #breastcancertreatment I #Drug I #AI I #Professor I #noveltreatmentstrategies I #multitargetdocking I Jamia Millia Islamia I Indian Council of Medical Research (ICMR) Read more: https://lnkd.in/gkCeqTje

Study links hormone therapy drugs to increased risk of heart conditions, blood clots Researchers, including those from Uppsala University, Sweden, said that certain tablets containing both oestrogen and progestogen are associated with a higher risk of heart disease and rare, but serious blood clots, known as venous thromboembolism. #hormonetherapy_drugs I #bloodclots I #oestrogen I #progestogen I #hormonereplacementtherapyrisks I #tibolone I #heartconditions Read more: https://lnkd.in/gadfU27E

Maternal deaths: Karnataka CM orders inquiry, suspension of drugs controller "I have asked for the drugs controller to be suspended immediately. I have directed to blacklist the Paschim Banga Pharmaceutical Ltd and to prosecute it. Also, it should be ensured that the company pays compensation to the victims," Siddaramaiah said. #Drugscontroller_suspension I #Karnataka I #CM I #Maternal_Death I #Inquiry I #Governmenthospitals I Government of Karnataka Read more: https://lnkd.in/gSs_Jjb6

Case against hosp for overpriced meds The medicines sold at exorbitant prices included IV injections, Avil injection (Pheniramine Maleate Injection), which is used to treat allergic conditions, and Zofer injection (Ondansetron injection), which is used to treat and prevent nausea and vomiting. #Overpricing | #Medicines | #EssentialCommoditiesAct | #DrugsPriceControlOrder | #ConsumerRights Read more: https://lnkd.in/eTg3BzaR